DUK vs PFE Stock Comparison
PFE currently leads DUK in this stock comparison, with AIQ scores of 64 vs 55. The clearest difference is value.
What is the main difference between DUK and PFE?
PFE leads the current stock comparison as Pfizer Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Duke Energy Corporation vs Pfizer Inc.
PFE leads
PFE leads by 9 AIQ points, primarily on Value and Quality, but the lead has narrowed from 16 points over 30 sessions. Wall Street currently favors DUK on target upside.
Competitive: 4 of 6 evidence groups support PFE, its lead is narrowing, and its signal state is cleanly positive.
Duke Energy Corporation
Pfizer Inc.
The Algovestiq AIQ Score currently favors PFE over DUK, 64 versus 55 as of Oct 31, 2026. PFE's advantage is driven primarily by stronger value and quality. PFE also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors DUK. 4 of 6 covered evidence groups favor PFE today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. PFE lead: Weakening — the AIQ differential moved from 16 to 9 points over 30 sessions. PFE leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.
Compare Duke Energy Corporation and Pfizer Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare DUK and PFE against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value53 vs 67PFE +14
- Quality45 vs 54PFE +9
- Momentum72 vs 77PFE +5
- Risk Resilience49 vs 53PFE +4
4 of 6 evidence groups favor PFE. PFE’s edge is concentrated in value and quality.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Momentum -9
No signal started or stopped since the prior session; its 3 active signals are unchanged.
Largest factor move: Momentum -2, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 6 active signals are unchanged.
PFE's lead widened by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — DUK and PFE both carry a full feed there.
The central trade-off
PFE (Pfizer Inc.): the stronger current systematic profile, led by value and quality.
DUK (Duke Energy Corporation): the counter-case, on fundamentals, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PFEPFE on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
DUKDUK on combined revenue and EPS growth.
Value
PFEPFE on the peer-relative Value factor, by 14 points.
Momentum
PFEPFE on the Momentum factor, by 5 points.
Lower downside
PFEPFE on Risk Resilience, by 4 points.
Analyst upside
DUKDUK on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors PFE, analyst targets favor DUK. That disagreement is the most useful thing on this page.
| Measure | DUK | PFE | Note |
|---|---|---|---|
| Implied upside to target | +4.1% | -5% | DUK has more room |
| Target dispersion | +14.3% | +24.1% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 10 | 6 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
Dividend growth
| Dividend metric | DUK | PFE |
|---|---|---|
| 5Y dividend CAGR | 2.01% | 2.50% |
| 2020 regular DPS | $3.820 | $1.520 |
| 2025 regular DPS | $4.220 | $1.720 |
| Years increased | 5 | 5 |
| No cut in window | Yes | Yes |
| Cohort rank | #329 | #315 |
PFE grew its split-adjusted regular dividend faster over 2020–2025 — 2.50% a year against DUK's 2.01%. Neither company reduced its regular dividend in any year of the window.
Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.
Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor PFE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PFE | 55 vs 64 |
| Fundamentals | DUKon balance | revenue growth -17.3% vs 4%; EPS growth -29.9% vs -109.2%; TTM ROE 9.9% vs 4.9%; gross margin 68.2% vs 71.3%; operating margin 27.6% vs 25.1% — DUK takes 3 of 5 decided legs, not all of them |
| Valuation | PFE | Value 53 vs 67 |
| Technicals | PFE | Price vs 50-day 7.1% vs 7.2%; vs 200-day -0.6% vs 10.1% |
| Risk Resilience | PFE | Risk Resilience 49 vs 53 |
| Analyst expectations | DUK | Target upside 4.1% vs -5% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of DUK and PFE and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 9 points.
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PFE.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28PFE lead: Weakening — the AIQ differential moved from 16 to 9 points over 30 sessions.
- Today
- PFE +9
- 55 vs 64
- 7 sessions ago
- PFE +7
- 57 vs 64
- 30 sessions ago
- PFE +16
- 45 vs 61
- 90 sessions ago
- PFE +18
- 46 vs 64
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 1 bearish, conflicted
Only DUK
- Death Cross Active — bearish, trend, long horizon (4.46%)
- Keltner Channel Breakout — bullish, volatility, short horizon
5 bullish / 0 bearish / 1 neutral
Only PFE
- Bollinger Band Squeeze — neutral, volatility, short horizon
- Golden Cross Active — bullish, trend, long horizon (6.39%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- 52-Week High Proximity — bullish, risk, long horizon (2.1%)
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: MACD Bullish Crossover.
DUK is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is up while the AIQ Score moved down 2 points over the same session — price and model disagree (price +1.18%, AIQ -2 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.9%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1DUK closes the Value gap — currently 14 points behind, the largest single contributor to PFE's edge.
- 2DUK's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3PFE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4The narrowing continues — the lead has already given back 7 points over 30 sessions, and a further 9-point move would eliminate PFE's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
DUK leads on balance| Metric | DUK | PFE |
|---|---|---|
| Revenue growth (YoY) | -17.3% | 4% |
| EPS growth (YoY) | -29.9% | -109.2% |
| Gross margin | 68.2% | 71.3% |
| Operating margin | 27.6% | 25.1% |
| Return on equity (TTM) | 9.9% | 4.9% |
| Debt to equity | 1.67 | 0.74 |
Performance
PFE leads 4 of 6 windows| Metric | DUK | PFE |
|---|---|---|
| 1 week (5 sessions) | 2.4% | -1.3% |
| 1 month (20 sessions) | 8.4% | 3.3% |
| 3 months (63 sessions) | -2.1% | 18.2% |
| 6 months (126 sessions) | -2.3% | 12.1% |
| Year to date | 5.4% | 18.3% |
| 1 year (252 sessions) | -3% | 18.9% |
Technicals
PFE has the stronger structure| Metric | DUK | PFE |
|---|---|---|
| RSI (14) | 68 | 68.3 |
| ADX (14) | 38.1 | 28.3 |
| Price vs 50-day | 7.1% | 7.2% |
| Price vs 200-day | -0.6% | 10.1% |
| Volatility (1M, annualized) | 20.5% | 21.4% |
Risk
PFE is the more resilient| Metric | DUK | PFE |
|---|---|---|
| Beta | -0.31 | 0.24 |
| Sharpe ratio | -0.26 | 0.78 |
| Sortino ratio | -0.41 | 1.34 |
| Max drawdown | -15.2% | -17.1% |
| Current drawdown | -7.4% | -3.2% |
| Annualized volatility | 16.6% | 21.6% |
| Value at risk (95%) | -1.7% | -2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, DUK or PFE?
On the Algovestiq AIQ Score, PFE is the stronger of the two as of Oct 31, 2026, scoring 64 against DUK's 55. The edge comes from value and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is DUK or PFE the better buy right now?
PFE carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor PFE over DUK?
The composite weights Quality, Value, Momentum and Risk Resilience. PFE leads Value by 14 points; PFE leads Quality by 9 points; PFE leads Momentum by 5 points. PFE leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by DUK simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.
Which has more analyst upside, DUK or PFE?
Analyst price targets imply +4.1% upside for DUK and -5% for PFE, so the Street currently favors DUK. That points the opposite way to the AIQ Score, which favors PFE. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, DUK or PFE?
PFE is the better-valued of the two on the peer-relative Value factor. PFE on the peer-relative Value factor, by 14 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, DUK or PFE?
DUK on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, DUK or PFE?
PFE on the Momentum factor, by 5 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, DUK or PFE?
PFE is the more resilient of the two, so the other name carries the higher downside risk. PFE on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is DUK more profitable than PFE?
The profitability evidence is mixed: gross margin 68.2% vs 71.3%; operating margin 27.6% vs 25.1%; ttm roe 9.9% vs 4.9%. DUK leads on two measures and PFE on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is PFE's lead over DUK getting stronger or weaker?
PFE lead: Weakening — the AIQ differential moved from 16 to 9 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has not changed hands in that window.
What would change the DUK vs PFE verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DUK closes the Value gap — currently 14 points behind, the largest single contributor to PFE's edge; DUK's Death Cross Active resolves — a bearish trend rule currently active against it; PFE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; the narrowing continues — the lead has already given back 7 points over 30 sessions, and a further 9-point move would eliminate PFE's advantage entirely.
What do the current signals say about DUK and PFE?
DUK: 2 bullish / 1 bearish, conflicted. PFE: 5 bullish / 0 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on DUK is Death Cross Active (bearish, long horizon). On PFE it is Golden Cross Active (bullish, long horizon).
Compare DUK and PFE with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.